NIH currently requires use of the fed-wide progress reporting format — known as the RPPR (Research Performance Progress Report) — to submit progress reports for Streamlined Non-competing Award Process (SNAP), fellowship, and multi-year funded awards. In April we opened the RPPR for use for all Type 5 Non-SNAP progress reports in anticipation of an October 2014 requirement for RPPR use.
Now, it’s official — all type 5 non-SNAP progress reports submitted on or after October 17, 2014 need to be submitted through the RPPR module of eRA Commons. …. Continue reading
True or false: iEdison is the newest Apple™ light bulb.
Well, for now at least, false. iEdison – which stands for “interagency Edison” – is a system for reporting inventions resulting from federal funding. iEdison is now part of NIH’s electronic Research Administration (eRA) suite of services, and our new website helps iEdison users access information and resources related to invention reporting. …. Continue reading
No. If you are appealing the initial peer review of your application, then the appeal must be resolved before you submit that application as either a resubmission (A1) or new application (A0).
Looking for more information on NIH’s resubmission policy? Visit our frequently asked questions about resubmission. Continue reading
A resubmission application, also known as an “A1” application, requires a one-page introduction that addresses the comments from the review of the prior A0 application as well as marked changes in the text of the Research Strategy. You are permitted one resubmission of an unfunded application to address reviewer comments, and that resubmission must be submitted to an appropriate due date no longer than 37 months …. Continue reading
Want to look into the future? We sure would. But in lieu of clairvoyant powers we’re trying the next best thing: a map to help navigate upcoming changes in grants administration. The grants policy page on grants.nih.gov is now home to an interactive timeline of upcoming changes in grants administration. …. Continue reading
Exemplifying and promoting the highest level of scientific integrity, public accountability, and social responsibility in the conduct of science are among NIH’s main goals as an agency. Research integrity is not about being flawless. It is about conducting science using honest and verifiable methods, complying with rules and regulations and adhering to professional standards. Ultimately, it is also about trust, the foundation upon which the scientific research enterprise is built. We’ve recently updated our website on research integrity, …. Continue reading
A new system for reporting and managing your clinical research inclusion data is on its way. Currently, grantees report on sex/gender, race, and ethnicity information as required by NIH’s policy on the Inclusion of Women and Minorities in Clinical Research, …. Continue reading
Yes. In any case in which HHS determines that an NIH-funded clinical research project’s purpose is evaluating the safety or effectiveness of a drug, medical device, or treatment, and that intervention has been designed, conducted, or reported by an investigator … Continue reading
As described in the 2011 revision, FCOI regulations apply to each institution applying for or receiving NIH grant or cooperative agreement funding, and to investigators who are planning to participate or are participating in NIH-supported research. However, this regulation does not apply to Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) Phase I applicants and recipients.
It’s important to remember that the regulatory definition of “investigator” is not limited to …. Continue reading
NIH (including help desks) will be closed Friday, July 4, 2014 (Independence Day). If a postmark/submission date falls on this federal holiday, the application deadline is automatically extended to the next business day. Continue reading